Longtunhub — Trading Ideas on TradingView

Gold ATH continues to set, looking to 4050 ⭐️GOLDEN INFORMATION: Gold (XAU/USD) extends its rally in the Asian session on Wednesday, breaking above the $4,000 mark for the first time ever. Expectations of further Fed rate cuts, persistent geopolitical tensions, and mounting economic uncertainty from the ongoing US government shutdown continue to fuel demand for the precious metal. ⭐️Personal comments NOVA: The current gold buying power in the market is very large, the weakening of DXY this year is the main reason for the very strong growth in gold prices. ⭐️SET UP GOLD PRICE: 🔥SELL GOLD zone: 4048 - 4050 SL 4055 TP1: $4040 TP2: $4030 TP3: $4020 🔥BUY GOLD zone: $3960-$3962 SL $3955 TP1: $3975 TP2: $3990 TP3: $4000 ⭐️Technical analysis: Based on technical indicators EMA 34, EMA89 and support resistance areas to set up a reasonable BUY order. ⭐️NOTE: Note: Nova wishes traders to manage their capital well - take the number of lots that match your capital - Takeprofit equal to 4-6% of capital account - Stoplose equal to 2-3% of capital account

recovery, towards 3400, gold price ⭐️GOLDEN INFORMATION: Gold prices (XAU/USD) extended their gains to around $3,365 during the early Asian session on Monday, as investors flocked to safe-haven assets in response to an escalation in global trade tensions. The move comes after US President Donald Trump intensified the trade war over the weekend, announcing a 30% tariff on imports from the European Union and Mexico, effective August 1. This followed last week’s declarations of a 35% duty on Canadian goods and a sweeping 15%–20% tariff proposal on most trading partners, in addition to a 50% tariff on copper imports. Mounting concerns over the economic fallout from these aggressive trade measures have fueled demand for gold, a traditional refuge during times of uncertainty. ⭐️Personal comments NOVA: Continued price increase, tariff pressure helps gold to be positive again ⭐️SET UP GOLD PRICE: 🔥SELL GOLD zone: 3384- 3386 SL 3391 TP1: $3376 TP2: $3364 TP3: $3352 🔥BUY GOLD zone: $3308-$3310 SL $3303 TP1: $3319 TP2: $3328 TP3: $3340 ⭐️Technical analysis: Based on technical indicators EMA 34, EMA89 and support resistance areas to set up a reasonable BUY order. ⭐️NOTE: Note: Nova wishes traders to manage their capital well - take the number of lots that match your capital - Takeprofit equal to 4-6% of capital account - Stoplose equal to 2-3% of capital account

short recovery, trend line ✍️ NOVA hello everyone, Let's comment on gold price next week from 07/14/2025 - 07/18/2025 ⭐️GOLDEN INFORMATION: Gold prices surged nearly 1% on Friday as market sentiment soured in response to US President Donald Trump’s controversial trade policies targeting Canada, while hinting at broader tariffs on other nations and copper. At the time of writing, XAU/USD is trading at $3,354, rebounding from intraday lows of $3,322. On Thursday, Trump announced a 35% tariff on Canadian imports, though goods complying with the 2020 USMCA trade agreement remain exempt. He also signaled intentions to expand tariffs across most trading partners, proposing blanket rates ranging from 15% to 20%. With a light US economic calendar, attention turned to Fed commentary. Chicago Fed President Austan Goolsbee pushed back on calls for rate cuts aimed at reducing government borrowing costs, stressing the central bank’s focus remains firmly on employment and price stability. ⭐️Personal comments NOVA: growth according to the trend, maintaining the accumulation price zone above 3300 🔥 Technically: Based on the resistance and support areas of the gold price according to the H4 frame, NOVA identifies the important key areas as follows: Resistance: $3392, $3447 Support: $3330, $3308, $3246 🔥 NOTE: Note: Nova wishes traders to manage their capital well - take the number of lots that match your capital - Takeprofit equal to 4-6% of capital account - Stoplose equal to 2-3% of capital account - The winner is the one who sticks with the market the longest

Novo Nordisk's The recent drop in Novo Nordisk's stock price is attributed to several factors. A key issue is the company’s struggle to meet the surging demand for its weight-loss drugs, such as Wegovy. Although demand remains strong, investors are concerned about Novo Nordisk's ability to scale up production and deliveries, which is creating downward pressure on the stock. Additionally, some recent financial results failed to meet Wall Street expectations. Despite revenue growth in key product categories, overall revenues in some reports came in below forecasts. This underperformance has contributed to a negative investor sentiment. However, analysts emphasize that Novo Nordisk's core products remain in high demand, and the company has significant long-term growth potential if it addresses its supply chain and production challenges